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Abstract
Background/Aim Food intake, eating behavior, and metabolic parameters in rats that underwent bilateral truncal vagotomy,
sleeve gastrectomy, and duodenal switch procedures were examined.
Methods Rats were subjected to bilateral truncal vagotomy plus pyloroplasty (VTPP), pyloroplasty (PP), laparotomy, sleeve
gastrectomy (SG), or duodenal switch (DS; with and without SG).
Results VTPP, but neither PP nor laparotomy, reduced body weight (BW; 10%) transiently (1 week postoperatively). SG
reduced BW (10%) for 6 weeks, while DS alone or SG followed by DS led to a continuous BW loss from 15% at 1 week to
50% at 8 weeks postoperatively. Food intake was higher and the satiety ratio was lower during the night than the day for all
groups of surgeries. Neither VTPP nor SG had measurable effect on food intake, eating behavior and metabolic parameters.
DS reduced daily food intake by more than 50%, which was associated with hypercholecystokinin(CCK)emia, reduced
meal size and increased satiety ratio, and increased fecal energy content (measured at 8 weeks).
Conclusions Weight loss after VTPP, SG, or DS differed in terms of degree, duration, and underlying mechanisms. DS
without SG was most effective in the long-term, probably due to hyperCCKemia-induced reduction in food intake and long-
limb intestinal bypass-induced malabsorption.
Keywords Body weight.Food intake.Obesity surgery Introduction
During the evolution of surgery for morbid obesity, many
different surgical procedures have been developed in order
to reduce food intake and/or nutrition absorption. For
instance, gastric bypass surgery is designed to create a
small pouch in the stomach to produce early satiety and a
consequent reduction in food intake, and moreover to
induce malabsorption by creating a short gut syndrome and/
or by accomplishing distal mixing of bile acid and
pancreatic juice with ingested nutrients, thereby reducing
absorption. It has also been demonstrated that weight loss
surgery, including gastric bypass, changes the perception of
food and thus eating behavior, leading to the concept of
“behavior surgery”.
1 We recently reported that rats devel-
oped an altered eating behavior for the short term, but not
the long term after gastric bypass. Gastric-bypassed rats ate
more during the daytime than sham-operated control rats
and were unable to keep up with the control rats with
respect to meal size and eating rate during the night. More
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reduced, despite the fact that the rats had a loss in body
weight following the gastric bypass.
2
Based on the hypothesis that “common obesity” has
hypothalamic origins, truncal vagotomy was used for
treatment of severe obesity.
3 Based on the understanding
that the vagus nerve controls satiety/hunger and energy
homeostasis, an alternative minimally invasive treatment,
the so-called “Vagal BLocking for Obesity Control”
(VBLOC), has been developed to intermittently block vagal
nerve trunks with high frequency and low power electrical
signals through the laparoscopically implanted device.
4
Hence, the first aim of the present study was to analyze
the eating behavior and energy expenditure in rats subjected
to bilateral truncal vagotomy. The measurements were
performed by utilizing a state-of-the-art method known as
a comprehensive laboratory animal metabolic monitoring
system (CLAMS), as performed in our previous studies.
2,5,6
Laparoscopically assisted vertical gastrectomy using a
Dexterity Pneumo Sleeve device, the so-called sleeve
gastrectomy, was originally proposed as the first stage
followed by Roux-en-Y gastric bypass or duodenal switch
as the second stage.
7,8 This procedure has been recently
considered as an independent weight loss surgery, based on
clinical outcomes and presumably underlying mechanism in
which the ghrelin-rich gastric fundus is eliminated and the
volume of the stomach is reduced.
9–12 Previously, we
compared the eating behavior in rats that underwent a total
gastrectomy vs. gastric bypass (i.e., end-to-end anastomosis
of esophagus–proximal jejunum) and found that the food
intake and meal size were reduced after gastrectomy but not
gastric bypass, thus suggesting that the control of food
intake was independent of the food reservoir function of the
stomach.
5 Therefore, the second aim of the present study
was to analyze the eating behavior and energy expenditure
in rats subjected to sleeve gastrectomy.
The duodenal switch procedure was originally created as
a surgical solution for primary bile reflux gastritis and/or to
decrease post-gastrectomy symptoms after distal gastrecto-
my and gastroduodenostomy.
13 Currently, a combined
procedure of sleeve gastrectomy and duodenal switch has
been applied to the treatment of morbid obesity based on
the rationale that the sleeve gastrectomy preserves the
pylorus and first portion of the duodenum which negates
the possibility of dumping symptoms and reduces the risk
of marginal ulcers.
8 The duodenal switch procedure
achieves complete pancreaticobiliary diversion. As a result,
postprandial biliary and pancreatic secretion will be
reduced or eliminated, and the negative feedback effect of
the bile acid and pancreatic juice on cholecystokinin
(CCK)-producing cells in the duodenum and jejunum will
be deprived, thereby leading to an increase in circulating
CCK levels. Since CCK is well known as a satiety
hormone, we hypothesized that the duodenal switch
procedure could be an independent weight loss surgery
because this procedure would reduce the food intake due to
hyperCCKemia and induce malabsorption due to long-limb
intestinal bypass. Hence, the third aim of the present study
was to evaluate the effects of a duodenal switch with and
without a sleeve gastrectomy on body weight, eating
behavior, serum CCK levels, fecal energy content, and
energy expenditure.
Materials and Methods
Animals
Male rats (Sprague–Dawley, 3 months old) were purchased
from Taconic M&B, Skensved, Denmark. The males were
preferred because females change their food intake during
ovulation and males grow faster than females, making it
easier to detect body weight change. The rats were housed
in individually ventilated Makrolon cages with 12 h light/
dark cycle, room temperature of 22°C and 40–60% relative
humidity. They were allowed free access to tap water and
standard rat pellet food (RM1 801002, Scanbur BK AS,
Sweden). The study was approved by the Norwegian
National Animal Research Authority (Forsøksdyrutvalget,
FDU).
Experimental Design
The animals were divided into the following groups:
laparotomy (LAP), pyloroplasty (PP), bilateral truncal vagot-
omy plus pyloroplasty (VTPP), sleeve gastrectomy (SG),
duodenal switch alone (DS), SG as the first stage and then DS
as the second stage (SG1+DS2), and SG and DS simulta-
neously (SG+DS). In consideration of the “3Rs” for the
human use of animals (e.g., reduction of animal numbers to
the minimum consistent with achieving the scientific
purposes of the experiment),
14 rats in control groups have
been re-used after a 9-week recovery from previous
operation and revealed an unchanged eating behavior and
metabolic parameters. The rats were first subjected to LAP
(n=7), PP (n=7), or VTPP (n=7), respectively. After
9 weeks, LAP and PP rats were subjected to SG and DS,
respectively. After an additional 11 weeks, SG rats were
subjected to DS, and VTPP rats were simultaneously
subjected to both SG and DS. An additional group of age-
matched rats were subjected to LAP (n=7).
Each rat was monitored weekly with respect to the body
weight development throughout the study period. Each rat
was placed in the CLAMS cage three times for 48 h, i.e.,
1 week before surgery, 1–2 and 8–11 weeks after surgery
for measurements of the eating and metabolic parameters.
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Rats were deprived of food but not water for 12 h pre- and
24 h post-operation. All operations were performed under
general anesthesia with isofluran (4% for induction and 2%
for maintenance). Buprenorphine (0.05 mg/kg) was admin-
istrated as a pain reliever subcutaneously immediately after
surgery. LAP was performed through middle-line incision.
PP was performed by cutting off the pyloric sphincter
(2 mm) and suturing it vertically against the incision. VTPP
was achieved by cutting both the anterior and posterior
vagal trunks immediately below the diaphragm and, while
at the same time performing a PP to prevent gastroparesis-
induced food retention and gastric dilation. SG was
performed by resecting 70% of the glandular stomach
along the greater curvature. DS was constructed by trans-
ecting the duodenum 1 cm to the pylorus, and a common
channel was created by dividing the ileum 5 cm proximal to
the ileocecal junction (rats have a much longer jejunum
than humans). The distal limb of the ileum was anasto-
mosed to the post-pyloric duodenum in an end-to-end
manner, and the stump of the duodenum was closed with
cross-suture. The distal anastomosis was performed by
joining the distal biliopancreatic limb at 1 cm to the
ileocecal junction in an end-to-side manner.
Eating and Metabolic Parameters
Eating and metabolic parameters were automatically
recorded by the comprehensive laboratory animal monitor-
ing system (CLAMS; Columbus Instruments International,
Columbus, OH, USA). This system is composed of a four-
chamber indirect calorimeter designed for the continuous
monitoring of individual rats from each chamber. An air
sample was withdrawn every 5 min. The energy expendi-
ture (kcal/h) was calculated according to equation: (3.815+
1.232 RER)×VO2, where the respiratory exchange ratio
(RER) was the volume of CO2 produced per volume of O2
consumed. VO2 was the volume of O2 consumed per hour
per kilogram of mass of the animal. The energy expenditure
is expressed as kcal/h/100 g body weight. Urine production
was automatically recorded by weight. In order for rats to
acclimate to this system, they were placed in these
metabolic cages for 24 h before the first CLAMS
monitoring. The high-resolution eating data was generated
by monitoring all eating balances every 0.5 s, providing
accumulated food intake, meal size, and meal duration. The
end of an eating event (meal) was when the balance was
stable for more than 10 s and a minimum of 0.05 g was
a
0
100
200
300
400
500
600
700
- 10123456789 1 0 11
SG
DS
DS1+SG2 SG1+DS2
0
100
200
300
400
500
600
- 10123456789
PP
VTPP
Weeks after Surgery
g
Weeks after Surgery
g
b
Fig. 1 Body weight developments after pyloroplasty (PP) and
bilateral truncal vagotomy plus pyloroplasty (VTPP) (a), and after
sleeve gastrectomy (SG), duodenal switch alone (DS) and SG as the
first stage and then DS as the second stage (SG1+DS2)( b). Data are
expressed as mean ± SEM
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Fig. 2 Calories intake (kcal/rat) during the day and the night at
1 week before (Pre), 1 and 9 weeks after bilateral truncal vagotomy
plus pyloroplasty (VTPP) (a), 1 week before (Pre), 2 and 11 weeks
after sleeve gastrectomy (SG) (b). Data are expressed as mean ± SEM.
ns not significant between pre- vs. post-operation
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included: meal size, meal duration, accumulated food
intake, intermeal interval, rate of eating, and satiety ratio.
The intermeal interval was defined as the interval in
minutes between two meals. The rate of eating was
calculated by dividing meal size by meal duration. The
satiety ratio, an index of non-eating time produced by each
gram of food consumed, was calculated as intermeal
interval divided by meal size. The rats were placed in the
CLAMS chambers for 48 h (data from the first 24 h were
not used in the analysis) with free access to standard rat
powder food (RM1 811004, Scanbur BK AS, Sweden) and
tap water. The total metabolizable energy was 2.57 kcal/g
for both RM1 801002 and 811004.
Determination of Energy Content in Feces
Feces were collected when the rats were placed in
CLAMS cages 8 weeks after DS or age-matched control
L A P ,a n dd r i e df o r7 2ha t6 0 ° C .T h ee n e r g yc o n t e n tw a s
determined by means of an adiabatic bomb calorimeter
(IKA-Calorimeter C 5000, IKA-Werke GmbH & Co. KG,
Staufen, Germany).
Determination of Serum CCK Levels
CCK levels in serum were analyzed by radioimmunoassay
with sulfated CCK-8 as standard, using a CCK kit (Euro-
diagnostica AB, Malmö, Sweden).
Statistical Analysis
The data were expressed as mean ± SEM. Comparisons
between surgical groups and between three time points
(1 week before, 1–2 and 8–11 weeks after surgery) were
performed using an independent sample t test or ANOVA
followed by a Tukey’s test when applicable. p<0.05 was
considered statistically significant.
Table 1 Eating and metabolic parameters at 1 week before VTPP, 1 and 9 weeks after VTPP
Parameters 1 W before VTPP 1 W after VTPP 9 W after VTPP
Daytime Food intake (g) 3.37±0.51 4.27±0.53 ns 4.08±0.31 ns
Food intake (g/100 g body weight) 0.74±0.11 1.11±0.18 ns 0.86±0.07 ns
Calories intake (kcal) 8.66±1.30 10.97±1.37 ns 10.49±0.79 ns
Calories intake (kcal/100 g body weight) 1.91±0.29 2.86±0.46 ns 2.20±0.18 ns
Number of meals 13.86±1.77 12.43±1.73 ns 15.57±1.95 ns
Meal size (g/meal) 0.25±0.03 0.39±0.07 ns 0.28±0.03 ns
Meal duration (min/meal) 1.00±0.20 1.81±0.52 ns 1.12±0.14 ns
Intermeal interval (min) 51.86±6.11 59.91±10.49 ns 46.82±6.47 ns
Satiety ratio (min/g) 230.76±43.10 165.10±20.64 ns 166.71±13.47 ns
Rate of eating (g/min) 0.27±0.02 0.27±0.04 ns 0.26±0.02 ns
Nighttime Food intake (g) 13.90±0.63 11.18±1.61 ns 12.80±0.70 ns
Food intake (g/100 g body weight) 3.06±0.15 2.72±0.26 ns 2.68±0.14 ns
Calories intake (kcal) 35.72±1.62 28.73±4.14 ns 32.89±1.80 ns
Calories intake (kcal/100 g body weight) 7.87±0.39 6.99±0.66 ns 6.88±0.36 ns
Number of meals 31.00±3.04 24.29±3.02 ns 31.00±5.32 ns
Meal size (g/meal) 0.46±0.03 0.48±0.06 ns 0.50±0.10 ns
Meal duration (min/meal) 1.96±0.29 2.64±0.46 ns 2.12±0.32 ns
Intermeal interval (min) 21.78±1.92 29.97±5.48 ns 25.66±5.36 ns
Satiety ratio (min/g) 46.70±2.27 65.33±10.13 ns 50.59±2.40 ns
Rate of eating (g/min) 0.25±0.02 0.20±0.03 ns 0.24±0.02 ns
24 h Energy expenditure (kcal/h/100 g body weight) 0.39±0.01 0.43±0.01 ns 0.36±0.01*
RER 0.95±0.01 0.93±0.01 ns 0.95±0.01 ns
Ambulatory activity 7,494.14±1,240.97 6,902.00±923.12 ns 6,504.00±999.08 ns
Data are expressed as mean ± SEM
ns not significant
*p<0.01 (1 W vs. 9 W)
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Mortality
There was no mortality in rats that underwent LAP, PP, or
VTPP. The mortality rate was one of seven in rats subjected
to SG, two of seven to DS alone, one of six to SG1+DS2,
and six of seven to SG+DS simultaneously.
Body Weight
Both LAP and PP had no effect on body weight
development. VTPP transiently reduced the body weight
(about 10% at 1 week postoperatively; Fig. 1a). SG reduced
the body weight (approximately 10%) for about 6 weeks
(Fig. 1b). DS alone or SG followed by DS reduced the
body weight in a similar manner: a rapid and continuous
weight loss of about 10% at 1 week and 50% at 8 weeks
postoperatively (Fig. 1b).
Food Intake, Eating Behavior, Energy Expenditure,
and Fecal Energy Content
Food intake was higher and the satiety ratio was lower
during the night than the day for each rat.
There were no differences between LAP and PP in terms
of food intake and eating behavior parameters at either 1 or
9 weeks postoperatively (data not shown).
VTPP was without any measurable effects on food
intake, eating behavior, and metabolic parameters measured
at either 1 or 9 weeks postoperatively (Fig. 2a; Table 1).
SG had no effects on food intake and eating behavior
parameters, except for meal duration during the night
measured at 2 weeks (Fig. 2b; Table 2). In addition, SG
reduced the water intake during one interval (0.91±0.07 vs.
0.47±0.07 mL at 2 weeks and vs. 0.45±0.08 mL at
11 weeks, both p<0.01). Energy expenditure was increased
at 2 weeks and RER was increased at 11 weeks postoper-
atively (Table 2).
Table 2 Eating and metabolic parameters at 1 week before SG, 2 and 11 weeks after SG
Parameters 1 W before SG 2 W after SG 11 W after SG
Daytime Food intake (g) 5.62±0.70 3.92±0.38 ns 4.76±0.63 ns
Food intake (g/100 g body weight) 1.01±0.15 0.77±0.07 ns 0.83±0.10 ns
Calories intake (kcal) 14.43±1.79 10.08±0.97 ns 12.24±1.62 ns
Calories intake (kcal/100 g body weight) 2.60±0.38 1.97±0.18 ns 2.13±0.27 ns
Number of meals 13.83±1.83 9.83±1.42 ns 11.17±1.54 ns
Meal size (g/meal) 0.41±0.01 0.44±0.08 ns 0.43±0.04 ns
Meal duration (min/meal) 1.52±0.13 1.72±0.20 ns 1.29±0.07 ns
Intermeal interval (min) 51.45±7.09 70.24±8.34 ns 62.28±7.13 ns
Satiety ratio (min/g) 124.13±14.28 170.13±18.28 ns 149.69±23.39 ns
Rate of eating (g/min) 0.28±0.02 0.25±0.03 ns 0.33±0.02 ns
Nighttime Food intake (g) 13.61±0.89 14.41±1.39 ns 13.47±0.69 ns
Food intake (g/100 g body weight) 2.43±0.17 2.80±0.22 ns 2.34±0.09 ns
Calories intake (kcal) 34.97±2.28 37.04±3.57 ns 34.63±1.78 ns
Calories intake (kcal/100 g body weight) 6.23±0.43 7.19±0.56 ns 6.01±0.22 ns
Number of meals 28.50±3.40 23.17±3.59 ns 28.00±4.27 ns
Meal size (g/meal) 0.50±0.06 0.73±0.15 ns 0.53±0.07 ns
Meal duration (min/meal) 1.69±0.19 2.88±0.47* 1.77±0.18 ns
Intermeal interval (min) 24.46±2.86 31.58±5.83 ns 26.76±5.05 ns
Satiety ratio (min/g) 48.93±3.63 45.93±4.93 ns 48.68±2.50 ns
Rate of eating (g/min) 0.30±0.00 0.25±0.02 ns 0.30±0.01 ns
24 h Energy expenditure (kcal/h/100 g body weight) 0.34±0.01 0.38±0.00* 0.37±0.01 ns
RER 0.96±0.01 0.94±0.01 ns 1.02±0.01**, ***
Ambulatory activity 7,014.50±1,001.57 6,721.17±807.00 ns 5,094.67±549.75 ns
Data are expressed as mean ± SEM
ns not significant
*p<0.05
**p<0.01 (pre vs. 2 W or 11 W)
***p<0.01 (2 W vs.11 W)
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reduced the daily food/calories intake by approximately 50%
when measured at 2 as well as 8 weeks postoperatively
(Fig. 3a; Table 3). The reduced food intake was associated
with a reduced meal size and an increased satiety ratio, but
not with the number of meals (Fig. 3b–d; Table 3). The fecal
energy content of DS rats was higher than that of control
LAP rats (20411.15±177.86 J/g vs. 18756.36±51.61 J/g,
p<0.001) at 8 weeks. It was difficult to collect the feces at
2 weeks after DS due to a severe diarrhea. There were no
differences between DS and SG1+DS2 in terms of food
intake and eating behavior parameters, except RER and
energy expenditure at 2 weeks and water intake at 8 weeks
postoperatively.
One surviving rat that was subjected to SG+DS had
reduced food intake and altered eating behavior, much like
the rats subjected to SG1+DS2. However, this was not
analyzed statistically.
Circulating CCK Levels
Serum CCK levels were 12.6±3.0 pmol/L in SG1+DS2
rats. This was more than ten times higher than the value of
rats subjected to the sham operation in our previous report
(plasma CCK levels were 1.1±0.5 pmol/L).
15 Unfortunate-
ly, there was a technical error in the determination of the
CCK levels in age-matched control LAP and DS rats in the
present study.
Discussion
The role of vagus in physiologically controlling eating
behavior has been studied during the past decades. It is
believed that food interacts with the gut to provide the brain
via vagal afferents with information regarding food com-
position, amount of ingested food and energy content. The
brain determines the rate of nutrient absorption, partition-
ing, storage, and mobilization through vagal efferents as
well as the sympathetic nervous system and hormonal
mechanisms.
16 This food–gut-brain axis is considered as an
autonomic neurohumoral pathway regulating energy ho-
meostasis. In the present study, disruption of the gut-brain
axis by VTPP was without any measureable effect on the
energy homeostasis. The body weight loss was slight (about
15%) and transient (1 week postoperatively). This may
explain why vagotomy as treatment for obesity has received
little attention since it was used 30 years ago.
3 However,
with the substantial need for effective treatment of obesity
at younger ages and the improved safety of laparoscopic
procedures, it has been suggested that surgical treatment
can be justified at lower levels of BMI, before the eating
disorder has become intractable and requires malabsorptive
operations. The possibility for utilizing a laparoscopic
abdominal vagotomy has been well discussed elsewhere.
17
SG weight loss surgery is believed to be restrictive as
well as a neurohormone-mediated procedure. The early
clinical results seem promising, but long-term data is still
needed to define the place of LSG within the bariatric
surgery armamentarium.
18,19 In the present study, SG
reduced the body weight by about 10% in the short-term
(1–6 weeks) but not in the long-term (after 7 weeks). The
reduction was not associated with reduced food intake but
possibly with increased energy expenditure, which is in line
with previous observations in rats subjected to total
gastrectomy or gastric bypass.
5 The underlying physiolog-
ical mechanisms are still unknown. It should also be
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seemed to drink frequently postoperatively, probably owing
to lower ghrelin and obestatin levels.
5,20,21
In the present study, DS alone and SG+DS exhibited
well-matched postoperative effects on body weight, meta-
bolic parameters and eating behavior, leading to a long
lasting and effective body weight loss. More interestingly,
the results of the present study support our hypothesis that
the DS procedure per se could be considered as an
independent weight loss surgery because this procedure
reduces the food intake due to hyperCCKemia and induces
malabsorption due to intestinal bypass. As expected after
pancreaticobiliary diversion,
15,22–24 circulating CCK levels
were elevated after SG1+DS2, which in turn increased the
satiety ratio and reduced meal size. Malabsorption is
believed to be due to long-limb intestinal bypass after DS.
In fact, DS patients also showed a decreased appetite and
continuously body weight loss.
25 In addition to CCK,
glucagon-like peptide-1 (GLP-1) levels in the circulation
have been reported to be elevated in rats subjected to
pancreaticobiliary diversion, which could have a beneficial
effect on ß cells in the pancreas.
26,27 Unfortunately, GLP-1
was not measured in the present study, thus it will be of
interest for future study.
In conclusion, VTPP, SG, and DS, like gastric bypass,
reduced the body weight, though the effectiveness and
underlying mechanisms appear different. Since obesity is
believed to a multifactorial disease, the options for the
treatment, including various surgical procedures, should be
individualized.
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Table 3 Eating and metabolic parameters at 1 week before DS both with and without SG, 2 and 8 weeks after DS both with and without SG
Parameters 1 W before operation 2 W after operation 8 W after operation
Daytime Food intake (g) 4.99±0.31 3.54±0.44* 4.30±0.44 ns
Food intake (g/100 g body weight) 0.92±0.05 0.87±0.11 ns 1.60±0.20**, ****
Calories intake (kcal) 12.83±0.79 9.11±1.14* 11.05±1.14 ns
Calories intake (kcal/100 g body weight) 2.36±0.13 2.25±0.28 ns 4.10±0.51**, ****
Number of meals 12.80±1.18 17.50±3.79 ns 25.70±4.86*
Meal size (g/meal) 0.41±0.03 0.24±0.03* 0.25±0.06*
Meal duration (min/meal) 1.33±0.10 2.35±0.41 ns 3.74±1.82 ns
Intermeal interval (min) 54.01±4.00 54.86±14.48 ns 42.19±12.04 ns
Satiety ratio (min/g) 134.37±8.03 210.35±29.60* 163.30±20.66 ns
Rate of eating (g/min) 0.31±0.01 0.13±0.03** 0.10±0.01**
Nighttime Food intake (g) 13.34±0.43 4.89±0.73** 6.16±0.54**
Food intake (g/100 g body weight) 2.47±0.12 1.19±0.17** 2.20±0.15****
Calories intake (kcal) 34.29±1.10 12.56±1.86** 15.82±1.38**
Calories intake (kcal/100 g body weight) 6.35±0.30 3.07±0.44** 5.65±0.39****
Number of meals 25.20±2.62 20.30±3.43 ns 31.20±4.48 ns
Meal size (g/meal) 0.58±0.05 0.28±0.06* 0.29±0.09*
Meal duration (min/meal) 1.96±0.19 3.64±1.28 ns 3.84±1.58 ns
Intermeal interval (min) 28.19±2.96 40.29±6.97 ns 27.13±7.01 ns
Satiety ratio (min/g) 48.90±1.66 161.24±26.37** 109.27±11.90*
Rate of eating (g/min) 0.30±0.01 0.10±0.01** 0.09±0.01**
24 h Energy expenditure (kcal/h/100 g body weight) 0.37±0.01 0.38±0.02 ns 0.43±0.01*, ***
RER 0.99±0.02 0.90±0.03 ns 1.11±0.07****
Ambulatory activity 5,410.30±696.92 5,773.60±891.92 ns 3,533.70±618.31 ns
Data are expressed as mean ± SEM
ns not significant
*p<0.05
**p<0.01 (pre vs. 2 W or 8 W)
***p<0.05
****p<0.01 (2 W vs. 8 W)
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Discussant
DR.THOMASH.MAGNUSON(Baltimore,MD): I wouldliketothank
Dr. Kodama and congratulate him on an excellent presentation, and he
and his coauthors on an excellent manuscript. They have given us some
important insights into how some these bariatric operations work from a
metabolic perspective. This is an important topic, with the ultimate goal
of better selecting the right operation for each individual patient.
They found, interestingly, that vagotomy alone or sleeve gastrec-
tomy alone seemed to have little impact on weight loss or eating
behavior, but the duodenal switch operation did have a dramatic
impact on weight loss and also altered energy expenditure.
I have a couple quick questions.
First, with regards to your sleeve gastrectomy model, it looks like
this didn’t work very well, but yet there’s other animal models, obese
rats and mice for example, as well as our human clinical experience,
showing that the sleeve works pretty well as an operation for weight
loss. I wonder if you could comment briefly on why your results differ
from that of others. Did you measure circulating levels of ghrelin,
which has been implicated as being important in the function of the
sleeve gastrectomy as an appetite suppressant?
The second question involves your duodenal switch model. It
looks like these animals lost dramatic weight, but was this really a
physiologic model? It seems like most of these animals had severe
diarrhea and over 30 or 40% of your animals actually died in the
study. Was this due to severe malnutrition? Did you measure
nutritional parameters, such as serum albumin levels, to make sure
this wasn’t a model of severe protein calorie malnutrition contributing
to the deaths and the severe diarrhea?
In addition, you measured CCK levels and postulated that that
might be an effect of the duodenal switch and its impact on satiety, but
did you think about measuring other GI peptides. GLP-1, adiponectin,
NPY and PYY have all been implicated as being important to weight
loss in animal models that bypass variable lengths of intestine.
Once again, I enjoyed your presentation.
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DR. YOSUKE KODAMA: Thank you very much for your comments.
In this study with normal rats, duodenal switch, but not vagotomy or
sleeve gastrectomy, resulted in the dramatic weight loss. It will be of
interest to repeat this study but with obese rats to see whether the
effect differs. We did not measure ghrelin levels in this study, because
we did not see a significant weight loss after the sleeve gastrectomy.
As reported in our manuscript, 2 of 7 rats died after duodenal
switch procedure alone, and 1 of 6 rats died after sleeve
gastrectomy as the first stage and duodenal switch as the second
stage. Such mortality is generally acceptable in the experimental
surgery with small animals. All survived animals from duodenal
switch had severe diarrhea but it lasted only for a short time
period (e.g. 2 weeks). We did not measure the serum albumin
levels. In the case that the two procedures were performed at the
same time, 6 of 7 rats died, which was most likely due to surgical
trauma.
This was our first experimental study suggesting that duodenal
switch alone might be used as an independent weight loss surgery. The
underlying mechanism should be further investigated, for example, by
measuring not only CCK but also other GI hormones as you have
suggested.
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